Earnings
LRMR
12.15
+7.52%
0.85
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-12-31
68.15M
24.49M
--
--
--
--
0.00
--
--
--
5.31M
--
97.95M
4.98M
--
--
--
--
--
--
1.76M
6.73M
104.69M
--
2.63M
0.00
--
--
--
--
--
6.36M
--
--
--
--
8.99M
0.00
--
--
--
6.00M
6.00M
14.99M
15.00K
155.29M
-65.61M
--
--
--
89.69M
89.69M
104.69M
FY 2019-12-31
27.21M
43.05M
--
--
--
--
243.00K
--
--
--
999.00K
--
71.50M
7.87M
--
--
--
--
--
--
1.36M
9.23M
80.73M
--
632.00K
0.00
--
--
--
--
--
4.29M
--
--
--
--
12.19M
8.46M
--
--
--
6.46M
14.92M
27.11M
37.00K
449.90M
-396.35M
--
--
--
53.62M
53.62M
80.73M
FY 2018-12-31
49.33M
68.73M
--
--
--
--
1.54M
--
--
--
1.73M
--
121.33M
375.00K
--
--
--
--
--
--
57.00K
432.00K
121.76M
--
3.59M
0.00
--
--
--
--
--
4.26M
--
--
--
--
13.31M
15.19M
--
--
--
--
15.19M
28.49M
37.00K
444.21M
-350.94M
--
--
--
93.27M
93.27M
121.76M
FY 2017-12-31
40.78M
61.27M
--
--
--
--
946.00K
--
--
--
1.93M
--
104.92M
528.00K
--
--
--
--
--
--
57.00K
585.00K
105.51M
--
3.02M
0.00
--
--
--
--
--
4.27M
--
--
--
--
7.29M
20.00M
--
--
--
--
20.00M
27.29M
27.00K
367.82M
-289.58M
--
--
--
78.22M
78.22M
105.51M
FY 2016-12-31
32.35M
96.84M
--
347.00K
--
--
347.00K
--
--
--
1.36M
--
130.90M
661.00K
--
--
--
--
--
--
61.00K
722.00K
131.62M
--
2.57M
406.00K
--
--
--
--
--
3.73M
--
--
--
--
9.89M
0.00
--
--
--
--
0.00
9.89M
27.00K
359.33M
-237.55M
--
--
--
121.73M
121.73M
131.62M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out LRMR latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Larimar Therapeutics recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.